Medication info

HyalJoint Injection (Sodium Hyaluronate)

Prescription medicationInjectionsExpired
Ingredient · strength
Sodium Hyaluronate›10mg / 1mL
Manufacturer / importer
Pamgen Science Co., Ltd.
Appearance
A colorless, transparent, viscous solution filled in a glass vial or colorless, transparent plastic vial (part of a pre-filled syringe system) with rubber stoppers at both ends.
Packaging
2.5 mL/1 vial, (2.5 mL/1 vial) X 5EA
Approval status
Expired

MFDS item code 201502254 · Notified 2015.04.15

This product's status changed to Expired on 2025.04.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of knee osteoarthritis and periarthritis of the shoulder
Who uses it
Adults
Adult dosage
Adults: Administer 25mg of sodium hyaluronate once weekly for 5 consecutive weeks into the knee joint cavity or shoulder joint (shoulder joint cavity, subacromial bursa, or tendon sheath of the long head of the biceps), with the number of doses adjusted as appropriate according to symptoms. Because this medicine is administered into the knee joint cavity, administration must be performed using strict aseptic technique.

Ingredients

Manufacturer
Pamgen Science Co., Ltd.

Efficacy & effects

Treatment of knee osteoarthritis and periarthritis of the shoulder

  • Osteoarthritis of the knee
  • periarthritis of the shoulder
View approved original text

This medicine is used for typical joint disorders such as osteoarthritis of the knee and periarthritis of the shoulder.

Dosage and Administration

Adult dosage

Adults: Administer 25mg of sodium hyaluronate once weekly for 5 consecutive weeks into the knee joint cavity or shoulder joint (shoulder joint cavity, subacromial bursa, or tendon sheath of the long head of the biceps), with the number of doses adjusted as appropriate according to symptoms. Because this medicine is administered into the knee joint cavity, administration must be performed using strict aseptic technique.

Precautions

This drug should not be used in patients with a history of hypersensitivity. As it is administered intra-articularly, avoid use if there is a skin disease or infection at the injection site. Use with caution in patients with liver dysfunction or a history of liver impairment. During administration, serious allergic reactions such as shock may occur, so patients should be closely monitored, and if abnormal symptoms appear, administration should be stopped immediately and appropriate treatment initiated. Hypersensitivity symptoms such as swelling, rash, and itching may occur, so administration should be stopped if these symptoms arise. Temporary pain, swelling, redness, and warmth may occur at the injection site, so caution is required. Symptoms such as nausea, vomiting, fever, and headache may also occur. It is preferable to alleviate inflammation before administering this drug to joints with severe inflammation. After administration, stabilizing the joint area is helpful, and care should be taken to prevent the drug from leaking outside the joint. Caution is advised in patients with rheumatoid arthritis or gout arthritis as inflammation may temporarily worsen. Avoid vigorous exercise or prolonged weight-bearing activities within 48 hours after administration. The safety of concurrent administration with other intra-articular injections has not been confirmed, so it is safer not to combine them. The safety of this drug has not been established for pregnant women or women who may become pregnant, so it should be used with caution only when necessary. Lactating women are advised to avoid breastfeeding as the drug may be transmitted in breast milk. The safety for children has not been established, so it should be administered with caution only when necessary. Elderly patients may have decreased physical function, so care is needed during administration. Maintain aseptic conditions during injection, and it is advisable to administer only up to 5 times if symptoms do not improve. If there is excessive joint fluid, it is recommended to aspirate it before administration. This drug is not intended for intravascular administration or ophthalmic use. Due to its high viscosity, care should be taken regarding the size of the injection needle, and the solution should flow well from the ampoule. To avoid foreign matter contamination when cutting the ampoule, it is better to disinfect first. Caution should be taken as precipitation may occur when mixed with certain disinfectants. It is for single use and should be used immediately after opening, with any remaining drug discarded. It is safer to administer this drug after local anesthesia has been given.

Side effects

Shock, edema (facial, eyelid, etc.), facial flushing, rash, hives, itching, pain (mainly transient pain after administration), swelling, ascites, redness, warmth, severe localized pressure sensation, petechiae, nausea, vomiting, fever, headache, worsening of local inflammation symptoms, localized pain, temporary increase in inflammation

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to avoid contact with air, ideally at room temperature between 1 degree and 30 degrees Celsius. Storing this way helps maintain the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

A colorless, transparent, viscous solution filled in a glass vial or colorless, transparent plastic vial (part of a pre-filled syringe system) with rubber stoppers at both ends.

Package unit

2.5 mL/1 vial, (2.5 mL/1 vial) X 5EA

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.